Literature DB >> 218427

Differences in metabolic responses to beta-adrenergic stimulation after propranolol or metoprolol administration.

T William-Olsson, E Fellenius, P Björntorp, U Smith.   

Abstract

Isoprenaline, or the beta 2-agonist terbutaline, was infused in healthy male volunteers and the plasma levels of insulin, glucose and free fatty acids (FFA) were determined. Saline, propranolol, or the selective beta 1-receptor antagonist, metoprolol, was administered i.v. prior to the infusion of the beta-stimulants. The two beta-receptor blockers inhibited isoprenaline-induced increase in chronotropy to about the same extent, while the effects on systolic and diastolic blood pressure were in accordance with a selective beta1-blocking effect of metoprolol and a non-selective beta-blocking action of propranolol. Quantitative differences were found between metoprolol and propranolol on the metabolic parameters. The effects can best be described in terms of beta 1- or beta 2-receptors, where effects on plasma FFA and glycerol levels seem to be mainly beta1-mediated. An apparent beta 2-mediated effect was found for insulin release and hepatic glucose output.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 218427     DOI: 10.1111/j.0954-6820.1979.tb06031.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  24 in total

1.  Evaluation of the metabolic responses to inhaled salbutamol in the measurement of beta 2-adrenoceptor blockade.

Authors:  B J Lipworth; L C McFarlane; W J Coutie; D G McDevitt
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

2.  Physical performance and serum potassium under chronic beta-blockade.

Authors:  T Kullmer; W Kindermann
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1985

3.  A comparison of the effects of flosequinan, a new vasodilator, and propranolol on sub-maximal exercise in healthy volunteers.

Authors:  H M Lewis; M J Kendall; S R Smith; J R Bratty
Journal:  Br J Clin Pharmacol       Date:  1989-05       Impact factor: 4.335

4.  Can the biochemical responses to a beta 2-adrenoceptor stimulant be used to assess the selectivity of beta-adrenoceptor blockers?

Authors:  S Rolf Smith; M J Kendall; D J Worthington; R Holder
Journal:  Br J Clin Pharmacol       Date:  1983-11       Impact factor: 4.335

Review 5.  Beta-adrenoceptor blocking agents and lipolysis.

Authors:  H H Harms; J De Vente; J Zaagsma
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 6.  [The influence of beta-receptor blockers on metabolism (author's transl)].

Authors:  F W Lohmann
Journal:  Klin Wochenschr       Date:  1981-01-15

7.  Effects of prazosin and alphamethyldopa on blood lipids and lipoproteins in hypertensive patients.

Authors:  M Velasco; H Silva; E Feldstein; R Pellicer; J Morillo; A Urbina-Quintana; O Hernández-Pieretti
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

8.  [Catecholamines, GH, cortisol, glucagon, insulin, and sex hormones in exercise and beta 1-blockade (author's transl)].

Authors:  W Kindermann; A Schnabel; W M Schmitt; G Biro; M Hippchen
Journal:  Klin Wochenschr       Date:  1982-05-17

9.  Effect of beta-blocking drugs on beta-cell function and insulin sensitivity in hypertensive non-diabetic patients.

Authors:  K Tötterman; L Groop; P H Groop; R Kala; E M Tolppanen; F Fyhrquist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Metabolic and hormonal responses to exhaustive supramaximal running with and without beta-adrenergic blockade.

Authors:  A Schnabel; W Kindermann; V Steinkraus; O Salas-Fraire; G Biro
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.